药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rolitetracycline
Rucaparib
The serum concentration of Rucaparib can be increased when it is combined with Dabrafenib.
Rolitetracycline
Glasdegib
The serum concentration of Glasdegib can be increased when it is combined with Dabrafenib.
Rolitetracycline
Segesterone acetate
The metabolism of Segesterone acetate can be increased when combined with Dabrafenib.
Rolitetracycline
Levosalbutamol
The excretion of Levosalbutamol can be decreased when combined with Dabrafenib.
Rolitetracycline
Technetium Tc-99m mebrofenin
The excretion of Technetium Tc-99m mebrofenin can be decreased when combined with Dabrafenib.
Rolitetracycline
Atrasentan
The excretion of Atrasentan can be decreased when combined with Dabrafenib.
Rolitetracycline
Relugolix
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Relugolix.
Rolitetracycline
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Dabrafenib.
Rolitetracycline
Gallopamil
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Gallopamil.
Rolitetracycline
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Dabrafenib.
Rolitetracycline
Lidoflazine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Lidoflazine.
Rolitetracycline
Bencyclane
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Bencyclane.
Rolitetracycline
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Tetrahydropalmatine.
Rolitetracycline
Lacidipine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Lacidipine.
Rolitetracycline
Aranidipine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Aranidipine.
Rolitetracycline
Pinaverium
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Pinaverium.
Rolitetracycline
Trimebutine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Trimebutine.
Rolitetracycline
Vilanterol
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Vilanterol.
Rolitetracycline
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Dabrafenib.
Rolitetracycline
Inotersen
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Inotersen.